The North America Eubiotics Market would witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Eubiotics aids in the enhancement of the immune system and therefore plays an important role in it. Eubiotics are natural digestive stimulants that help to maintain a healthy bacteria balance in the gastrointestinal system. Dietary organic acids have a eubiotic influence on the multiplication of indigenous lactic acid bacteria, which helps to activate the immunological response to illnesses. Prebiotics, probiotics, and organic acids are examples of feed additives. Eubiotics are beneficial to digestive health and can be used in place of antibiotics in feed.
The term 'eubiosis' has entered the lexicon since routine use of antibiotics in cattle is no longer appropriate, and prophylactic/metaphylactic use would be phased out in the coming years. It's a completely different approach to animal health, instead of attacking the microbiome with antibiotics, nurture and collaborate with the beneficial microorganisms. Eubiosis refers to the microflora of the gastrointestinal tract being in ideal balance. It is one of the most important variables in animal performance and immune development. Feed additives that have been demonstrated to promote eubiosis and overcome dysbiosis, or a mismatch in the microbiota of the gastrointestinal system, can be highly beneficial.
Probiotics described as "living microorganisms that impart a health benefit on the host when taken in suitable proportions," are finally becoming a viable alternative for gastroenterologists in Canada and the United States. Unfortunately, neither Health Canada nor the US Food and Drug Administration has implemented United Nations or World Health Organization standards to regulate the use of the term "probiotic." As a result, there is a slew of 'probiotic' products on the market that aren't probiotic. The purpose of this research was to explore the justification for probiotics in gastroenterology, along with the products available to physicians in Canada and which one’s patients may be taking.
For preweaning calves in USA dairy cattle, actual deaths of 5% and morbidity rates of 34% have been recorded. Furthermore, infections that occur during the newborn stage, particularly diarrhea, have a significant impact on growth throughout the raising phase, long-term future performance, and genetic potential for future herd improvements. It is crucial to provide feed additives to promote a neonatal calf's immunity and health, especially during the critical first weeks of life. Understanding the link between management techniques, dietary strategies, and calf health is critical for reducing morbidity and mortality while also increasing future production.
The US market dominated the North America Eubiotics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,375 million by 2028. The Canada market is experiencing a CAGR of 9.3% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 8.3% during (2022 - 2028).
Based on Product, the market is segmented into Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes. Based on Application, the market is segmented into Gut Health, Immunity, Yield, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on End-use, the market is segmented into Poultry Feed, Swine Feed, Cattle Feed, Aquatic Feed, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Eubiotics Market is Predict to reach $7.2 Billion by 2028, at a CAGR of 7.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.
By Product
- Probiotics
- Organic Acids
- Phytogenic
- Prebiotics
- Enzymes
By Application
- Gut Health
- Immunity
- Yield
- Others
By Form
By End-use
- Poultry Feed
- Swine Feed
- Cattle Feed
- Aquatic Feed
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- Novozymes A/S
- BASF SE
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Lallemand, Inc.
- Lesaffre Group
- Kemin Industries, Inc.
- Cargill Corporation
- Calpis Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Eubiotics Market, by Product
1.4.2 North America Eubiotics Market, by Application
1.4.3 North America Eubiotics Market, by Form
1.4.4 North America Eubiotics Market, by End-use
1.4.5 North America Eubiotics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Eubiotics Market
Chapter 4. North America Eubiotics Market by Product
4.1 North America Probiotics Market by Country
4.2 North America Organic Acids Market by Country
4.3 North America Phytogenic Market by Country
4.4 North America Prebiotics Market by Country
4.5 North America Enzymes Market by Country
Chapter 5. North America Eubiotics Market by Application
5.1 North America Gut Health Market by Country
5.2 North America Immunity Market by Country
5.3 North America Yield Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Eubiotics Market by Form
6.1 North America Solid Market by Country
6.2 North America Liquid Market by Country
Chapter 7. North America Eubiotics Market by End-use
7.1 North America Poultry Feed Market by Country
7.2 North America Swine Feed Market by Country
7.3 North America Cattle Feed Market by Country
7.4 North America Aquatic Feed Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Eubiotics Market by Country
8.1 US Eubiotics Market
8.1.1 US Eubiotics Market by Product
8.1.2 US Eubiotics Market by Application
8.1.3 US Eubiotics Market by Form
8.1.4 US Eubiotics Market by End-use
8.2 Canada Eubiotics Market
8.2.1 Canada Eubiotics Market by Product
8.2.2 Canada Eubiotics Market by Application
8.2.3 Canada Eubiotics Market by Form
8.2.4 Canada Eubiotics Market by End-use
8.3 Mexico Eubiotics Market
8.3.1 Mexico Eubiotics Market by Product
8.3.2 Mexico Eubiotics Market by Application
8.3.3 Mexico Eubiotics Market by Form
8.3.4 Mexico Eubiotics Market by End-use
8.4 Rest of North America Eubiotics Market
8.4.1 Rest of North America Eubiotics Market by Product
8.4.2 Rest of North America Eubiotics Market by Application
8.4.3 Rest of North America Eubiotics Market by Form
8.4.4 Rest of North America Eubiotics Market by End-use
Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:
TABLE 1 North America Eubiotics Market, 2018 - 2021, USD Million
TABLE 2 North America Eubiotics Market, 2022 - 2028, USD Million
TABLE 3 North America Eubiotics Market by Product, 2018 - 2021, USD Million
TABLE 4 North America Eubiotics Market by Product, 2022 - 2028, USD Million
TABLE 5 North America Probiotics Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Probiotics Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Organic Acids Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Organic Acids Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Phytogenic Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Phytogenic Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Prebiotics Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Prebiotics Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Eubiotics Market by Application, 2018 - 2021, USD Million
TABLE 16 North America Eubiotics Market by Application, 2022 - 2028, USD Million
TABLE 17 North America Gut Health Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Gut Health Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Immunity Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Immunity Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Yield Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Yield Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Eubiotics Market by Form, 2018 - 2021, USD Million
TABLE 26 North America Eubiotics Market by Form, 2022 - 2028, USD Million
TABLE 27 North America Solid Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Solid Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Liquid Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Liquid Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Eubiotics Market by End-use, 2018 - 2021, USD Million
TABLE 32 North America Eubiotics Market by End-use, 2022 - 2028, USD Million
TABLE 33 North America Poultry Feed Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Poultry Feed Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Swine Feed Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Swine Feed Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Cattle Feed Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Cattle Feed Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Aquatic Feed Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Aquatic Feed Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Eubiotics Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Eubiotics Market by Country, 2022 - 2028, USD Million
TABLE 45 US Eubiotics Market, 2018 - 2021, USD Million
TABLE 46 US Eubiotics Market, 2022 - 2028, USD Million
TABLE 47 US Eubiotics Market by Product, 2018 - 2021, USD Million
TABLE 48 US Eubiotics Market by Product, 2022 - 2028, USD Million
TABLE 49 US Eubiotics Market by Application, 2018 - 2021, USD Million
TABLE 50 US Eubiotics Market by Application, 2022 - 2028, USD Million
TABLE 51 US Eubiotics Market by Form, 2018 - 2021, USD Million
TABLE 52 US Eubiotics Market by Form, 2022 - 2028, USD Million
TABLE 53 US Eubiotics Market by End-use, 2018 - 2021, USD Million
TABLE 54 US Eubiotics Market by End-use, 2022 - 2028, USD Million
TABLE 55 Canada Eubiotics Market, 2018 - 2021, USD Million
TABLE 56 Canada Eubiotics Market, 2022 - 2028, USD Million
TABLE 57 Canada Eubiotics Market by Product, 2018 - 2021, USD Million
TABLE 58 Canada Eubiotics Market by Product, 2022 - 2028, USD Million
TABLE 59 Canada Eubiotics Market by Application, 2018 - 2021, USD Million
TABLE 60 Canada Eubiotics Market by Application, 2022 - 2028, USD Million
TABLE 61 Canada Eubiotics Market by Form, 2018 - 2021, USD Million
TABLE 62 Canada Eubiotics Market by Form, 2022 - 2028, USD Million
TABLE 63 Canada Eubiotics Market by End-use, 2018 - 2021, USD Million
TABLE 64 Canada Eubiotics Market by End-use, 2022 - 2028, USD Million
TABLE 65 Mexico Eubiotics Market, 2018 - 2021, USD Million
TABLE 66 Mexico Eubiotics Market, 2022 - 2028, USD Million
TABLE 67 Mexico Eubiotics Market by Product, 2018 - 2021, USD Million
TABLE 68 Mexico Eubiotics Market by Product, 2022 - 2028, USD Million
TABLE 69 Mexico Eubiotics Market by Application, 2018 - 2021, USD Million
TABLE 70 Mexico Eubiotics Market by Application, 2022 - 2028, USD Million
TABLE 71 Mexico Eubiotics Market by Form, 2018 - 2021, USD Million
TABLE 72 Mexico Eubiotics Market by Form, 2022 - 2028, USD Million
TABLE 73 Mexico Eubiotics Market by End-use, 2018 - 2021, USD Million
TABLE 74 Mexico Eubiotics Market by End-use, 2022 - 2028, USD Million
TABLE 75 Rest of North America Eubiotics Market, 2018 - 2021, USD Million
TABLE 76 Rest of North America Eubiotics Market, 2022 - 2028, USD Million
TABLE 77 Rest of North America Eubiotics Market by Product, 2018 - 2021, USD Million
TABLE 78 Rest of North America Eubiotics Market by Product, 2022 - 2028, USD Million
TABLE 79 Rest of North America Eubiotics Market by Application, 2018 - 2021, USD Million
TABLE 80 Rest of North America Eubiotics Market by Application, 2022 - 2028, USD Million
TABLE 81 Rest of North America Eubiotics Market by Form, 2018 - 2021, USD Million
TABLE 82 Rest of North America Eubiotics Market by Form, 2022 - 2028, USD Million
TABLE 83 Rest of North America Eubiotics Market by End-use, 2018 - 2021, USD Million
TABLE 84 Rest of North America Eubiotics Market by End-use, 2022 - 2028, USD Million
TABLE 85 Key Information – Koninklijke DSM N.V.
TABLE 86 key Information – Novozymes A/S
TABLE 87 Key Information – BASF SE
TABLE 88 Key Information –DuPont de Nemours, Inc.
TABLE 89 Key Information – Chr. Hansen Holding A/S
TABLE 90 key Information – Lallemand, Inc.
TABLE 91 Key Information – Lesaffre Group
TABLE 92 Key Information – Kemin Industries, Inc.
TABLE 93 Key Information – Cargill Corporation
TABLE 94 Key Information – Calpis Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Koninklijke DSM N.V.